These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

826 related items for PubMed ID: 23540260

  • 1. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, Shin DH, Doh FM, Koo HM, Ko KI, Kim CH, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH.
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [Abstract] [Full Text] [Related]

  • 2. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 3. In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria.
    Hage V, Pelletier S, Dubourg L, Drai J, Cuerq C, Lemoine S, Hadj-Aissa A, Laville M, Fouque D.
    J Ren Nutr; 2014 Nov; 24(6):390-4. PubMed ID: 25193108
    [Abstract] [Full Text] [Related]

  • 4. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E, Thodis E, Arsos G, Pasadakis P, Panagoutsos S, Papadopoulou D, Papagianni A.
    Kidney Blood Press Res; 2020 Nov; 45(6):900-915. PubMed ID: 33040068
    [Abstract] [Full Text] [Related]

  • 5. Plasma s-Klotho is related to kidney function and predicts adverse renal outcomes in patients with advanced chronic kidney disease.
    Liu QF, Ye JM, Yu LX, He AL, Sun Q, He DW, Li SS.
    J Investig Med; 2018 Mar; 66(3):669-675. PubMed ID: 29061648
    [Abstract] [Full Text] [Related]

  • 6. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [Abstract] [Full Text] [Related]

  • 7. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.
    Kacso IM, Bondor CI, Kacso G.
    Clin Biochem; 2012 Nov; 45(16-17):1415-20. PubMed ID: 22836100
    [Abstract] [Full Text] [Related]

  • 8. Klotho and Clinical Outcomes in CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Edmonston D, Fuchs MAA, Burke EJ, Isakova T, Wolf M, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.
    Am J Kidney Dis; 2024 Sep; 84(3):349-360.e1. PubMed ID: 38583756
    [Abstract] [Full Text] [Related]

  • 9. Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.
    Scholze A, Liu Y, Pedersen L, Xia S, Roth HJ, Hocher B, Rasmussen LM, Tepel M.
    J Clin Endocrinol Metab; 2014 May; 99(5):E855-61. PubMed ID: 24606097
    [Abstract] [Full Text] [Related]

  • 10. Serum bicarbonate and long-term outcomes in CKD.
    Menon V, Tighiouart H, Vaughn NS, Beck GJ, Kusek JW, Collins AJ, Greene T, Sarnak MJ.
    Am J Kidney Dis; 2010 Nov; 56(5):907-14. PubMed ID: 20605301
    [Abstract] [Full Text] [Related]

  • 11. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY, Milovanov YS, Kudryavtseva DV, Markina MM, Milovanova SY, Kozlovskaya LV, Lebedeva MV, Beketov VD, Moiseev SV, Mukhin NA, Fomin VV, Svistunov AA.
    Ter Arkh; 2015 Nov; 87(6):10-16. PubMed ID: 26281189
    [Abstract] [Full Text] [Related]

  • 12. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID.
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [Abstract] [Full Text] [Related]

  • 13. [Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease].
    Milovanova LIu, Milovanov IuS, Kozlovskaia LV, Mukhin NA.
    Ter Arkh; 2014 Oct; 86(4):36-44. PubMed ID: 24864466
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F, MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [Abstract] [Full Text] [Related]

  • 15. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C, Cheng C, Wang J, Zhang L, Purrunsing Y, Yang G, Zeng M, Huang H, Ren W, Ye Y, Ma H, Xing C, Wang N.
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [Abstract] [Full Text] [Related]

  • 16. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease.
    Sawires HK, Essam RM, Morgan MF, Mahmoud RA.
    Nephron; 2015 Feb; 129(4):293-9. PubMed ID: 25766835
    [Abstract] [Full Text] [Related]

  • 17. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
    Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Levey AS, Lewis EF, McMurray JJ, Parving HH, Solomon SD, Pfeffer MA.
    Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
    [Abstract] [Full Text] [Related]

  • 18. Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease.
    Yasuda K, Kimura T, Sasaki K, Obi Y, Iio K, Yamato M, Rakugi H, Isaka Y, Hayashi T.
    Nephrol Dial Transplant; 2012 Oct; 27(10):3885-91. PubMed ID: 23114906
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease.
    Liu Z, Zhou H, Chen X, Chen H, Wang Y, Wang T, Cai L, Hong Y, Ke H, Zheng J.
    Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.